Senior insider sale
Chief Operating Officer at CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$3.64M
95.07K shares
What this filing means
KNIGHT JEFF E. plans to sell 95.07K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $3.64M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/8/2026ACC: 0001950047-26-003337
Officer· Chief Operating Officer
Since Aug 2021
95.07K
Shares to sell
$3.64M
Approx. market value
85.16K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
Exercise of Stock Options
Cash
4/8/2026
78.43KEmployee Stock Purchase Plan
Cash
5/20/2025
438.00Restricted Stock Units
N/A
3/15/2024
6.29KTotal acquired85.16K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/8/2026 | Exercise of Stock Options Cash | 78.43K | — |
5/20/2025 | Employee Stock Purchase Plan Cash | 438.00 | — |
3/15/2024 | Restricted Stock Units N/A | 6.29K | — |
| Total | 85.16K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
9.91K
Market value
$370.4K
3/16/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
85.16K
Market value
$3.27M
4/8/2026
Total
Units
95.07K
Value
$3.64M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/16/2026 | 9.91K | $370.4K | — | Completed |
| Planned — Approximate Date | ||||
4/8/2026 | 85.16K | $3.27M | NASDAQ | Planned |
| Total | 95.07K | $3.64M | ||